Scenarios that move MRVI

Maravai LifeSciences Holdings, Inc. - Class A common stock

Scenarios that move MRVI: 1 analysis, 1 positive, 0 negative.

1. 2026-10-05 · Novartis acquires Abogen in $7.8B RNA therapeutics deal — ▲ · impact +50 · confidence low · horizon quarters

All scenarios · Run a scenario · Pricing